924296-18-4 Usage
Uses
Used in Pharmaceutical Industry:
9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-[(phenylmethoxy)imino]is used as a potential pharmaceutical agent for its potential pharmacological and biological activities. The specific application reason is due to its unique structure and the presence of the phenylmethoxy group, which may contribute to its efficacy in various therapeutic areas.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-[(phenylmethoxy)imino]is used as a subject of study for its potential to contribute to drug discovery. The interest in 9H-Indeno[1,2-b]pyrazine-2,3-dicarbonitrile, 9-[(phenylmethoxy)imino]- lies in exploring its biological activities and understanding how its structure can be optimized for specific therapeutic targets.
Check Digit Verification of cas no
The CAS Registry Mumber 924296-18-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,4,2,9 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 924296-18:
(8*9)+(7*2)+(6*4)+(5*2)+(4*9)+(3*6)+(2*1)+(1*8)=184
184 % 10 = 4
So 924296-18-4 is a valid CAS Registry Number.
InChI:InChI=1/C20H11N5O/c21-10-16-17(11-22)24-20-18(23-16)14-8-4-5-9-15(14)19(20)25-26-12-13-6-2-1-3-7-13/h1-9H,12H2
924296-18-4Relevant articles and documents
Synthesis and biological evaluation of 9-oxo-9hindeno[1,2-b]pyrazine-2,3- dicarbonitrile analogues as potential inhibitors of deubiquitinating enzymes
Colombo, Matteo,Vallese, Stefania,Peretto, Ilaria,Jacq, Xavier,Rain, Jean-Christophe,Colland, Frederic,Guedat, Philippe
experimental part, p. 552 - 558 (2010/12/25)
High-throughput screening highlighted 9-oxo-9H-indeno[1,2-b]pyrazine-2,3- dicarbonitrile (1) as an active inhibitor of ubiquitin-specific proteases (USPs), a family of hydrolytic enzymes involved in the removal of ubiquitin from protein substrates. The chemical behavior of compound 1 was examined. Moreover, the synthesis and in vitro evaluation of new compounds, analogues of 1, led to the identification of potent and selective inhibitors of the deubiquitinating enzyme USP8.
Novel cysteine protease inhibitors and their therapeutic applications
-
Page/Page column 24, (2008/06/13)
The present invention concerns new compounds of formula (I), their process of preparation and their therapeutic use.